Lustgarten Foundation Advances Pancreatic Cancer Research Through Partnerships with the Opening of Two New Laboratories

September 21, 2018

The Lustgarten Foundation is pleased to announce two new pancreatic cancer research laboratories through respective partnerships with Dana-Farber Cancer Institute and Massachusetts Institute of Technology (MIT). The opening of these Lustgarten Foundation Pancreatic Cancer Research Laboratories will usher in a new era of research progress and represents an initial $10…

Continue reading

Finding New Ways of Treating Pancreatic Cancer

September 11, 2018

When he walks into Dana-Farber Cancer Institute every day, medical oncologist Brian Wolpin, MD, MPH, isn’t just prepared to treat the patients who await him inside. As director of Dana-Farber’s Gastrointestinal Cancer Center and Hale Center for Pancreatic Cancer Research, he’s also constantly thinking about how new research could improve…

Continue reading

Drs. Aguirre, Hahn and Wolpin published a study in Cancer Discovery that reported on real-time genomic characterization of advanced pancreatic cancer to enable precision medicine.

September 1, 2018

Drs. Aguirre, Hahn and Wolpin published a study in Cancer Discovery that reported on real-time genomic characterization of advanced pancreatic cancer to enable precision medicine. (Aguirre AJ, et al. Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine. Cancer Discov. 2018;8(9):1096-111. Epub 2018/06/16. doi: 10.1158/2159-8290.CD-18-0275. PubMed PMID: 29903880.). Read the…

Continue reading